These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
54. Suprachoroidal Triamcinolone Acetonide for Retinal Vein Occlusion: Results of the Tanzanite Study. Campochiaro PA; Wykoff CC; Brown DM; Boyer DS; Barakat M; Taraborelli D; Noronha G; Ophthalmol Retina; 2018 Apr; 2(4):320-328. PubMed ID: 31047241 [TBL] [Abstract][Full Text] [Related]
55. Melt-Cast Films Significantly Enhance Triamcinolone Acetonide Delivery to the Deeper Ocular Tissues. Tatke A; Dudhipala N; Janga KY; Soneta B; Avula B; Majumdar S Pharmaceutics; 2019 Apr; 11(4):. PubMed ID: 30987011 [TBL] [Abstract][Full Text] [Related]
56. A more efficient ocular delivery system of triamcinolone acetonide as eye drop to the posterior segment of the eye. Li J; Cheng T; Tian Q; Cheng Y; Zhao L; Zhang X; Qu Y Drug Deliv; 2019 Dec; 26(1):188-198. PubMed ID: 30835587 [TBL] [Abstract][Full Text] [Related]
57. Novel Triamcinolone Acetonide-Loaded Liposomes Topical Formulation for the Treatment of Cystoid Macular Edema After Cataract Surgery: A Pilot Study. Gonzalez-De la Rosa A; Navarro-Partida J; Altamirano-Vallejo JC; Hernandez-Gamez AG; Garcia-Bañuelos JJ; Armendariz-Borunda J; Santos A J Ocul Pharmacol Ther; 2019 Mar; 35(2):106-115. PubMed ID: 30614750 [TBL] [Abstract][Full Text] [Related]
58. In Situ Gel of Triamcinolone Acetonide-Loaded Solid Lipid Nanoparticles for Improved Topical Ocular Delivery: Tear Kinetics and Ocular Disposition Studies. Tatke A; Dudhipala N; Janga KY; Balguri SP; Avula B; Jablonski MM; Majumdar S Nanomaterials (Basel); 2018 Dec; 9(1):. PubMed ID: 30591688 [TBL] [Abstract][Full Text] [Related]
59. OCULAR HYPERTENSION AFTER INTRAVITREAL INJECTION OF 2-MG TRIAMCINOLONE. Storey PP; Obeid A; Pancholy M; Goodman J; Borkar D; Su D; Regillo C Retina; 2020 Jan; 40(1):75-79. PubMed ID: 30308561 [TBL] [Abstract][Full Text] [Related]
60. Periocular Triamcinolone vs. Intravitreal Triamcinolone vs. Intravitreal Dexamethasone Implant for the Treatment of Uveitic Macular Edema: The PeriOcular vs. INTravitreal corticosteroids for uveitic macular edema (POINT) Trial. Thorne JE; Sugar EA; Holbrook JT; Burke AE; Altaweel MM; Vitale AT; Acharya NR; Kempen JH; Jabs DA; Ophthalmology; 2019 Feb; 126(2):283-295. PubMed ID: 30269924 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]